CRIS Current Research Information System

FABBRI, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 7.095
NA - Nord America 6.675
EU - Europa 4.338
SA - Sud America 585
AF - Africa 315
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 8
Totale 19.036
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.524
SG - Singapore 2.047
CN - Cina 1.923
VN - Vietnam 1.176
IT - Italia 893
GB - Regno Unito 762
FR - Francia 636
DE - Germania 597
HK - Hong Kong 582
SE - Svezia 500
BR - Brasile 457
IN - India 339
KR - Corea 261
BD - Bangladesh 248
RU - Federazione Russa 218
IE - Irlanda 169
JP - Giappone 144
NL - Olanda 94
AT - Austria 79
ZA - Sudafrica 78
ID - Indonesia 74
CA - Canada 71
CI - Costa d'Avorio 64
SC - Seychelles 64
FI - Finlandia 59
AR - Argentina 55
UA - Ucraina 49
EE - Estonia 48
JO - Giordania 48
MX - Messico 48
TG - Togo 48
IQ - Iraq 37
PL - Polonia 37
CH - Svizzera 33
BG - Bulgaria 32
PH - Filippine 30
TR - Turchia 29
TH - Thailandia 25
PK - Pakistan 24
CO - Colombia 20
EC - Ecuador 20
BE - Belgio 19
AU - Australia 18
ES - Italia 17
GR - Grecia 17
UZ - Uzbekistan 16
SA - Arabia Saudita 15
IL - Israele 14
CZ - Repubblica Ceca 12
HU - Ungheria 12
JM - Giamaica 11
MA - Marocco 11
DK - Danimarca 10
TW - Taiwan 10
MY - Malesia 9
TN - Tunisia 9
VE - Venezuela 9
AZ - Azerbaigian 8
EG - Egitto 8
ET - Etiopia 7
EU - Europa 7
PY - Paraguay 7
LB - Libano 6
LT - Lituania 6
NO - Norvegia 6
PE - Perù 6
CL - Cile 5
PA - Panama 5
RO - Romania 5
SK - Slovacchia (Repubblica Slovacca) 5
AE - Emirati Arabi Uniti 4
DZ - Algeria 4
GH - Ghana 4
HR - Croazia 4
IR - Iran 4
KE - Kenya 4
NP - Nepal 4
SY - Repubblica araba siriana 4
AL - Albania 3
BW - Botswana 3
CR - Costa Rica 3
KG - Kirghizistan 3
NG - Nigeria 3
SI - Slovenia 3
UY - Uruguay 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BO - Bolivia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
OM - Oman 2
PR - Porto Rico 2
PT - Portogallo 2
RS - Serbia 2
SN - Senegal 2
Totale 19.015
Salva come PNG Salva come JPEG
Città #
Singapore 1.369
Fairfield 667
Ashburn 663
Southend 633
Hefei 594
Hong Kong 541
San Jose 459
Santa Clara 338
Seattle 293
Woodbridge 286
Cambridge 278
Hanoi 262
Ho Chi Minh City 262
Seoul 252
Wilmington 250
Chandler 243
Houston 232
Princeton 214
Beijing 182
Bologna 181
Ann Arbor 178
Boardman 176
Los Angeles 174
Dallas 166
Dublin 166
Lauterbourg 154
Tokyo 127
Dong Ket 104
Council Bluffs 101
New York 86
Frankfurt am Main 82
Buffalo 76
Abidjan 64
Westminster 62
San Diego 58
Bengaluru 57
Nanjing 57
Rome 55
Haiphong 53
Padova 52
São Paulo 51
Redondo Beach 50
Vienna 49
Jakarta 48
Lomé 48
Milan 47
Amman 46
Berlin 46
Turin 46
Da Nang 42
Chicago 40
Shenyang 36
Helsinki 35
The Dalles 35
Guangzhou 34
Shanghai 33
London 32
Nuremberg 32
Jinan 30
Saint Petersburg 30
Sofia 29
Naples 26
Olalla 25
Paris 23
Bern 22
Hebei 22
Mülheim 22
Orem 22
Tianjin 22
Warsaw 22
Montreal 21
Tongling 21
Munich 20
Nanchang 20
North Charleston 20
Phoenix 20
Baghdad 19
Boston 19
Bühl 19
Des Moines 19
Changsha 18
Lappeenranta 18
Mexico City 18
Xi'an 18
Wuhan 17
Hangzhou 15
Palermo 15
Biên Hòa 14
Brasília 14
Hải Dương 14
Jiaxing 14
Toronto 14
Walnut Creek 14
Amsterdam 13
Brooklyn 13
Chennai 13
Falkenstein 13
Rio de Janeiro 13
San Francisco 13
Belo Horizonte 12
Totale 11.783
Salva come PNG Salva come JPEG
Nome #
Genetica dei comportamenti impulsivo-aggressivi: possibile applicazione in psichiatria forense? 451
Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone 371
The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges 228
Side effects associated with psychotropic medications in patients with bipolar disorder: evidence from two independent samples. 223
CHL1, ITGB3 and SLC6A4 gene expression and antidepressant drug response: Results from the Munich Antidepressant Response Signature (MARS) study 220
The bidirectional interaction between antidepressants and the gut microbiota: are there implications for treatment response? 218
Age of onset in schizophrenia spectrum disorders: Complex interactions between genetic and environmental factors 210
Specific symptomatology profile associated with treatment resistant depression: A multicentric study from the Group for the Study of Resistant Depression with a focus on sex 209
A model to investigate SNPs' interaction in GWAS studies 196
Hypomanic symptoms in major depressive disorder: Prognostic impact and treatment issues 190
The comparative effects of risperidone long-acting injection and paliperidone palmitate on social functioning in schizophrenia: A 6-month, open-label, randomized controlled pilot trial 185
Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial 179
Progress and prospects in pharmacogenetics of antidepressant drugs 178
Association between CANCA1C gene rs1034936 polymorphism and alcohol dependence in bipolar disorder 176
Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: A 6-month, open-label, randomized, pilot trial 172
TPH1, MAOA, serotonin receptor 2A and 2C genes in citalopram response: possible effect in melancholic and psychotic depression. 171
A machine learning approach to predict treatment efficacy and adverse effects in major depression using CYP2C19 and clinical-environmental predictors 168
Consensus paper of the WFSBP Task Force on Genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response 168
Anhedonia is associated with a specific depression profile and poor antidepressant response 166
Cariprazine specificity profile in the treatment of acute schizophrenia: A meta-Analysis and meta-regression of randomized-controlled trials 166
Neuronal cell adhesion genes and antidepressant response in three independent samples 165
Exploring the use of immunomethylomics in the characterization of depressed patients: A proof-of-concept study 164
Epigenetic basis of psychiatric disorders: a narrative review 162
Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance 160
Pharmacological treatments for psychotic depression: a systematic review and network meta-analysis 154
HTR1A polymorphisms and clinical efficacy of antipsychotic drug treatment in schizophrenia: A meta-analysis 154
The Genetics of Treatment-Resistant Depression: A Critical Review and Future Perspectives 154
Pleiotropic genes in psychiatry: Calcium channels and the stress-related FKBP5 gene in antidepressant resistance 152
Clinical features and drug induced side effects in early versus late antidepressant responders. 150
Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy. 150
22q11.2 rearrangements: clinical and research implications of population-based risk of neuropsychiatric and developmental disorders 149
Early antidepressant efficacy modulation by glutamatergic gene variants in the STAR(⁎)D. 148
Anxiety disorders and age-related changes in physiology 145
Genetics of psychotropic medication induced side effects in two independent samples of bipolar patients 145
HTR1A gene polymorphisms and 5-HT1A receptor partial agonist antipsychotics efficacy in Schizophrenia 144
Pharmacogenetics in major depression: a comprehensive meta-analysis. 143
Genome-wide association study of antidepressant response: Involvement of the inorganic cation transmembrane transporter activity pathway 143
Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism. 142
Insulin resistance and poorer treatment outcomes in depression: evidence from UK Biobank primary care data 141
Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study 141
No effect of serotoninergic gene variants on response to interpersonal counseling and antidepressants in major depression. 140
Predictors of switch from depression to mania in bipolar disorder 139
Add-on benzodiazepine treatment in patients with major depressive disorder – results from a European cross-sectional multicenter study 139
Obsessive-Compulsive, Psychotic, and Autism Dimensions Overlap in Real World: A Case Report 137
Genetic basis of Bipolar disorder 137
Pharmacogenetics of antidepressants. 136
Social withdrawal as a trans-diagnostic predictor of short-term remission: a meta-analysis of five clinical cohorts 135
Mechanisms of antidepressant action: an integrated dopaminergic perspective. 135
Screening genetic variability at the CNR1 gene in both major depression etiology and clinical response to citalopram treatment. 134
Genetics of serotonin receptors and depression: state of the art. 134
Remifentanil in electroconvulsive therapy: a systematic review and meta-analysis of randomized controlled trials 133
Pharmacogenetics in Psychiatry 132
Corrected QT Interval Prolongation in Psychopharmacological Treatment and Its Modulation by Genetic Variation 132
Schizophrenia-Like Symptoms in Narcolepsy Type 1: Shared and Distinctive Clinical Characteristics 131
The sociodemographic and clinical phenotype of European patients with major depressive disorder undergoing first-line antidepressant treatment with NaSSAs 130
Role of 108 schizophrenia-associated loci in modulating psychopathological dimensions in schizophrenia and bipolar disorder 129
Mirtazapine blood levels and antidepressant response 128
Polygenic risk scores for neuropsychiatric, inflammatory, and cardio-metabolic traits highlight possible genetic overlap with suicide attempt and treatment-emergent suicidal ideation 127
Serotonin 7 Receptor Variants Are Not Associated with Response to Second-Generation Antipsychotics in Japanese Schizophrenia Patients 126
Genetics of resilience: Implications from genome-wide association studies and candidate genes of the stress response system in posttraumatic stress disorder and depression 125
Clinical insights into the cross-link between mood disorders and type 2 diabetes: A review of longitudinal studies and Mendelian randomisation analyses 124
Genetic basis of psychopathological dimensions shared between schizophrenia and bipolar disorder 123
Clinical Correlates and Outcome of Major Depressive Disorder and Comorbid Migraine: A Report of the European Group for the Study of Resistant Depression 123
Shared genetics among major psychiatric disorders. 122
Genetic variants associated with psychotic symptoms across psychiatric disorders 122
Comparison of Mortality Rates between Italian and Foreign-born Patients with Alcohol Use Disorders 122
Depressive symptoms and neuroticism-related traits are the main factors associated with wellbeing independent of the history of lifetime depression in the UK Biobank 121
Pharmacogenetics of antidepressant response. 121
Genetics of long-term treatment outcome in bipolar disorder 121
Melancholic features and typical neurovegetative symptoms of major depressive disorder show specific polygenic patterns 120
The dilemma of polypharmacy in psychosis: is it worth combining partial and full dopamine modulation? 119
Genetics of second-generation antipsychotic and mood stabilizer-induced weight gain in bipolar disorder: Common and specific effects of key regulators of fat-mass homoeostasis genes 119
Clinical application of antidepressant pharmacogenetics: Considerations for the design of future studies 118
Biomarkers of treatment-resistant schizophrenia: A systematic review 117
Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples 117
The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder 116
Machine Learning Prediction of Comorbid Substance Use Disorders among People with Bipolar Disorder 116
Trans-ancestry genome-wide study of depression identifies 697 associations implicating cell types and pharmacotherapies 116
Evidence on sociodemographic and clinical correlates of antidepressant combination or augmentation with second-generation antipsychotics in major depressive disorder 115
The link between cognition and somatic conditions related to insulin resistance in the UK Biobank study cohort: a systematic review 115
Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research. 115
DISC1-TSNAX and DAOA genes in major depression and citalopram efficacy 115
Real-world characteristics of European patients receiving SNRIs as first-line treatment for major depressive disorder 113
Identifying the Common Genetic Basis of Antidepressant Response 113
Age as a moderating factor of treatment resistance in depression 113
Imputed expression of schizophrenia-associated genes and cognitive measures in patients with schizophrenia 112
Pharmacogenetics and depression: A critical perspective 112
The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries 111
Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder 111
Refining prediction in treatment-resistant depression: Results of machine learning analyses in the TRD III sample 110
Pharmacogenetics of Major Depressive Disorder: Top Genes and Pathways Toward Clinical Applications 108
Genetics in psychiatry: Methods, clinical applications and future perspectives 107
Clinical, demographic, and genetic risk factors of treatment-attributed suicidality in >10,000 Australian adults taking antidepressants 106
Correlation between emotion dysregulation and mood symptoms of bipolar disorder: A systematic review and meta-analysis 105
Pharmacogenetic tests to guide drug treatment in depression: Comparison of the available testing kits and clinical trials 105
Reduced CXCL1/GRO chemokine plasma levels are a possible biomarker of elderly depression 105
Is Pharmacogenetics Useful in Antidepressant Treatment? 104
Cost-effectiveness of genetic and clinical predictors for choosing combined psychotherapy and pharmacotherapy in major depression 102
The Effects of CYP2C19 Genotype on Proxies of SSRI Antidepressant Response in the UK Biobank 101
Genetic underpinnings of sociability in the general population 101
Totale 14.466
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.219
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.219
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021305 0 0 0 0 0 0 0 0 0 0 0 305
2021/20221.727 122 85 82 52 154 122 48 256 75 140 311 280
2022/20231.881 170 229 118 176 111 149 111 142 344 54 164 113
2023/2024696 46 115 53 63 45 84 69 62 30 68 38 23
2024/20253.450 74 373 220 221 531 215 249 116 117 258 322 754
2025/20268.237 589 977 964 642 640 382 993 407 1.297 529 505 312
Totale 19.453